DNA mismatch repair deficiency test

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Monoclonal antibody (immune) 1 substance
PARP inhibitor 1 substance
Phase II: 1 Phase I: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II

1 trial
  • Institut Gustave Roussy Academic
    DOSTARLIMAB; NIRAPARIB
    2024-514855-13-00 1 country n=112
    Ended

Phase I

1 trial
  • Beigene Ltd. Commercial
    IMP not specified
    2023-503996-38-00 1 country 2025 n=60
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Beigene Ltd. Commercial 1 Phase I 0
Institut Gustave Roussy Academic 1 Phase II 0
New trials by year
2025
1
← All indication landscapes